Logo

American Heart Association

  15
  0


Final ID: MP2442

Measured Fontan conduit size and functional capacity: An analysis of the FORCE registry

Abstract Body (Do not enter title and authors here): Total cavo-pulmonary connection (Fontan) is the final stage of single ventricle palliation. In patients with an extracardiac (EC) Fontan, the synthetic conduit connecting the inferior vena cava to the pulmonary artery does not grow and may become smaller over time.

We hypothesize that smaller measured Fontan conduit diameter will be associated with lower functional capacity as measured by percent predicted peak VO2 (ppVO2).

A cross-sectional analysis of the FORCE registry was performed. Cardiac magnetic resonance imaging (CMR), exercise stress test (EST), and clinical data were extracted. Patients with EC-Fontan who had a CMR and EST within 1 year of each other from Jan 2003-June 2024 were included. Fontan conduits were manually segmented in 3D-Slicer. Center-line based assessments of conduit diameter were performed using circle-equivalent (CE) and maximum inscribed sphere (MIS) techniques (Figure 1). The relationships between minimum and length-averaged CE and MIS diameters indexed to body surface area (BSA) and percent predicted VO2 (ppVO2) were examined in bivariate and multivariable analyses, controlling for known predictors of exercise performance in Fontan patients: ventricular morphology, ventricular ejection fraction, atrioventricular valve regurgitation, time since Fontan, and presence of a patent fenestration.

Adequate imaging was present in 393 patients, of these 311 patients from 27 contributing centers had complete data for EST and CMR analysis. The median age at the time of CMR was 15.5 years and the median time between CMR and EST was 61 days. The median ppVO2 was 59% (IQR 50-68%). The median minimum Fontan conduit diameters by MIS and CE respectively were 14.6mm (IQR 13.1-16.0mm) and 17.1mm (IQR 15.8-18.7mm), while the median length-averaged Fontan conduit diameters by MIS and CE were 16.1mm (IQR 14.7-17.3mm) and 18.5 (IQR 17.0-20.0mm) (Figure 2). After indexing to BSA all four measures were associated with ppVO2, but average MIS was slightly more predictive, so was used in the multivariable model (Figure 3). After controlling for the known predictors listed above, each mm/m2 increase in measured conduit diameter was associated with a 1.6% increase in ppVO2 (p<0.001).

Fontan diameter is extremely variable across individuals. Smaller indexed Fontan conduit diameter is associated with lower functional capacity as measured by ppVO2. Further data is needed to determine if strategies to increase Fontan conduit size improve functional capacity.
  • Ohalloran, Conor  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Robinson, Joshua  ( LURIE CHILDRENS HOSPITAL , Chicago , Illinois , United States )
  • Alsaied, Tarek  ( UPMC Children’s Hospital of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Wang, Alan  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Ward, Kendra  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Mines, Ellen  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Lemley, Bethan  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Husain, Nazia  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Desai, Lajja  ( Lurie Children's Hospital , Chicago , Illinois , United States )
  • Rathod, Rahul  ( BOSTON CHILDREN'S HOSPITAL , Boston , Massachusetts , United States )
  • Author Disclosures:
    Conor Ohalloran: DO NOT have relevant financial relationships | Joshua Robinson: DO NOT have relevant financial relationships | Tarek Alsaied: DO NOT have relevant financial relationships | Alan Wang: DO NOT have relevant financial relationships | Kendra Ward: DO NOT have relevant financial relationships | Ellen Mines: DO NOT have relevant financial relationships | Bethan Lemley: DO NOT have relevant financial relationships | Nazia Husain: DO NOT have relevant financial relationships | Lajja Desai: DO NOT have relevant financial relationships | Rahul Rathod: DO have relevant financial relationships ; Research Funding (PI or named investigator):Mezzion Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

More abstracts on this topic:
Acceptability and Feasibility Of A Digital Health Intervention For Adults with Congenital Heart Disease

Valente Joseph, Reardon Leigh, Moons Philip, Okumura Megumi, Gurvitz Michelle, Agarwal Anushree, Banala Keerthana, Buenrostro Karina, Alano Lindsay, Duan Rong, Parang Kim, Manyan Karina, Bravo-jaimes Katia, Norris Mark

Clinical Case:
Flipping the Script: Tackling CAD in Dextrocardia During Cardiac Catheterization

Riya Fnu, Iqbal Naveed

More abstracts from these authors:
Feasibility of automated, deep learning-based segmentation of the Fontan aorta in 4D Flow MRI: A Fontan Outcome Registry using Cardiac Magnetic Resonance Examination (FORCE) Study

Mines Ellen, Desai Lajja, Rigsby Cynthia, Robinson Joshua, Berhane Haben, Johnson Ethan, Markl Michael, Ward Kendra, Wang Alan, Lemley Bethan, Ohalloran Conor, Husain Nazia

Cardiac Magnetic Resonance Imaging in Pediatric Heart Transplant Recipients: Correlation With Cardiopulmonary Exercise Testing

Tucker Sarah, Griffith Garett, Desai Lajja, Wang Alan, Gambetta Katheryn, Ward Kendra, Husain Nazia

You have to be authorized to contact abstract author. Please, Login
Not Available